1 |
nucleoside reverse transcriptase inhibitor
(910 times)
|
Acquired Immunodeficiency Syndrome (325 times)
|
NNRTI (304 times) PI (252 times) ART (192 times)
|
1997 Recent advances in antiretroviral therapy and HIV infection monitoring.
|
2 |
nucleoside RT inhibitor
(44 times)
|
Acquired Immunodeficiency Syndrome (12 times)
|
RT (37 times) NNRTI (20 times) PI (10 times)
|
1999 Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients.
|
3 |
nucleoside reverse transcriptase
(10 times)
|
Acquired Immunodeficiency Syndrome (3 times)
|
PI (5 times) HIV-1 (2 times) NNRTI (2 times)
|
1999 Failure of double protease inhibitor therapy as a salvage therapy for HIV-infected patients resistant to conventional triple therapy.
|
4 |
nucleoside analog RT inhibitor
(8 times)
|
Virology (3 times)
|
RT (7 times) HIV-1 (5 times) AZT (1 time)
|
2001 Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein.
|
5 |
HIV-strains resistant to nucleoside analogues
(1 time)
|
Virology (1 time)
|
TAMs (1 time) TDF (1 time) VL (1 time)
|
2006 Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.
|
6 |
multi-NRTI 'resistance
(1 time)
|
Pharmacology (1 time)
|
---
|
2007 Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study.
|
7 |
near-real-time imaging
(1 time)
|
Radiology (1 time)
|
AD (1 time)
|
2004 Visualization of the articular disk of the temporomandibular joint in near-real-time MRI: feasibility study.
|
8 |
non-reversed transcriptase inhibitor
(1 time)
|
Chemistry Techniques, Analytical (1 time)
|
AIDS (1 time)
|
2009 Improvement of sensitivity and selectivity of high-performance liquid chromatography for anti-retroviral drugs (non-reverse transcriptase inhibitors) by diamond-electrode electrochemical and fluorescence detection.
|
9 |
novel 2'-deoxyguanosine analogue reverse transcriptase inhibitor
(1 time)
|
Nephrology (1 time)
|
---
|
2001 Pharmacokinetics of abacavir in HIV-1-infected patients with impaired renal function.
|
10 |
nucleos(t)ide reverse transcriptase inhibitor-associated mutations
(1 time)
|
Medicine (1 time)
|
ART (1 time) CI (1 time) HIV-1 (1 time)
|
2011 Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
|
11 |
nucleoside analogue inhibitor of RT
(1 time)
|
Virology (1 time)
|
NNRTI (1 time) ORF (1 time) re (1 time)
|
2021 Combination of Antiretroviral Drugs Zidovudine and Efavirenz Impairs Tumor Growths in a Mouse Model of Cancer.
|
12 |
nucleoside inhibitors of HIV reverse transcriptase
(1 time)
|
Biochemistry (1 time)
|
AZT (1 time) ddI (1 time) ph-AZT (1 time)
|
2003 In vitro study of resistance-associated genotypic mutations to nucleoside analogs.
|
13 |
nucleotide RTI
(1 time)
|
Anti-Bacterial Agents (1 time)
|
HIV-1 (1 time) NNRTI (1 time) RT (1 time)
|
2009 Reverse transcriptase inhibitors as potential colorectal microbicides.
|
14 |
numerous approved anti-HIV drugs including both nucleoside inhibitor
(1 time)
|
Virology (1 time)
|
---
|
2008 Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase.
|
15 |
triple-nucleoside RT inhibitor
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
ddI (1 time) NAM (1 time) RT (1 time)
|
2003 Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.
|